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Abstract 
Background: Patient and public involvement (PPI) in research has increased steadily over the last two decades 
and is now both expected and appropriately resourced by many funding bodies, including the National Institute for 
Health Research (NIHR). However, PPI in research occurs in many different capacities and numerous frameworks exist 
for reporting or appraising patient involvement activities. The aim of this article is to describe processes involving PPI 
contributions to an NIHR-funded mixed-methods feasibility study (MoTaStim-Foot). Details of PPI advisors’ input, from 
initial identification and prioritisation of research ideas, to research delivery and dissemination, are discussed.
Methods: Extensive PPI for MoTaStim-Foot is reported, with consideration of Research Design Service (RDS) advice 
for PPI for research, involving identifying and prioritising: design; grant proposal development; undertaking/managing 
research; analysing and interpreting; dissemination; implementation; monitoring and evaluation. Two PPI workshops 
were undertaken; success in meeting UK standards for public involvement was audited against specific success crite-
ria by two researchers, with discussion and consideration regarding how well our PPI achieved inclusive opportuni-
ties, working together, support and learning, governance, communications and impact. How PPI can be improved for 
future trials was also considered. Although the advantages of PPI for researchers were considered, the benefits for PPI 
advisors were also analysed.
Results: UK standards for public involvement were achieved, along with seven relevant research processes sug-
gested by the RDS. PPI advisor contributions: informed study design; contributed to successful funding; enhanced 
trial delivery by informing participant information sheets and daily diaries; added value through undertaking note-
taker roles in focus groups and helping to analyse focus group transcripts; and assisted in dissemination. However, 
benefits were mutual with PPI advisors reporting feeling valued and respected, a sense of pride with renewed confi-
dence and purpose in life.
Conclusions: Importance and value of PPI, to researchers and patient advisors, have been highlighted, reinforcing 
the benefits of working in partnership with PPI advisors.
Trial registration ISRCTN 13676183; Central Portfolio Management System ID 30449. Registered 02/01/2015, https:// 
www. isrctn. com/ ISRCT N1367 6183.
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Background
First described as an idea in 2007 by the Department 
of Health [2], ‘personal and public involvement’ has 
evolved over the years. Definitions for patient and public 
involvement (PPI), as it is now more commonly known, 
have been suggested, with Rise et al. [3] highlighting the 
importance of mutual respect and discussions to reach 
collective decision making. INVOLVE, a national advi-
sory group commenced in 1996, funded by the National 
Institute for Health Research (NIHR), supported active 
public involvement in the National Health Service (NHS), 
public health and social research [4], but was taken over 
by the NIHR Centre for Engagement and Dissemina-
tion in April 2020. The NIHR define public involvement 
in research as "research being carried out ‘with’ or ‘by’ 
members of the public rather than ‘to’, or ‘about’ or ‘for’ 
them" (p 6) [5]. The inclusion of PPI advisors in research 
has been steadily increasing over the last two decades and 
researchers have moved from feeling uncomfortable and 
apprehensive as a result of what was an unfamiliar way 
of working with PPI advisors [6] to PPI advisors’ contri-
butions being commonplace [7]. Indeed, PPI is expected 
for some funding bodies, for example, the NIHR [8, 9]. 
Allowing appropriate allocation of costs for PPI when 
submitting grant applications has facilitated opportuni-
ties for PPI advisors [10]. Various ideas exist for public 
involvement activities, and activities are often poorly 
defined in the literature [11]; consequently, evaluating the 
impact of PPI for research is challenging [12], although 
some useful models have been suggested [13]. In fact, a 
recent systematic review found 65 published frameworks 
to appraise or report PPI within medical research and 
the authors proposed that a locally developed bespoke 
frame-working process for PPI should be co-designed to 
address this gap [14]. Indeed, the value of such collabora-
tive workshops with PPI advisors has already been dem-
onstrated at Keele University when developing a training 
programme with our PPI advisors [15].
This paper will inform how PPI advisor contributions 
were successfully integrated within an NIHR funded ran-
domised, mixed-methods feasibility study (MoTaStim-
Foot) hosted at Keele University; the mutual value both to 
the research team and the PPI advisors will be discussed. 
This study was funded by the NIHR as part of a personal 
fellowship and, therefore, there was not a PPI advisor as 
a co-applicant; however, PPI advisor contributions were 
integral throughout the study. It is hoped that this exam-
ple of public involvement within the research process will 
contribute to existing good practice case studies [16–18], 
enabling other researchers and PPI advisors to learn and 
begin to understand true mutual value of PPI. The aim 
of the PPI advisor contributions within the trial was to 
enable valuable insights from the perspective of a stroke 
survivor or carer during the complete research cycle, 
from designing the study to the implementation of find-
ings, evaluation and dissemination phases of the research 
journey for the MoTaStim-Foot feasibility study, adding 
value and making the study more relevant and credible. 
Our PPI advisors were carefully selected from a pool of 
people expressing an interest in informing our research, 
and were able to contribute effectively to the research 
process because they are experts in the area of stroke, 
gained from their lived experiences [19].
Methods
Aim, design and setting of the study
The MoTaStim-Foot study was a pilot and feasibility 
study in which two groups received sensory stimulation 
Plain English summary 
This article reports and analyses our public involvement in the research processes for a study funded by the National 
Institute for Health Research, the MoTaStim-Foot feasibility study. MoTaStim-Foot explored whether it was feasible 
to deliver treatments to help people feel their foot better after stroke. The results of this study have been published 
elsewhere (1). Patient and Public Involvement (PPI) advisors played an important role. They worked voluntarily, actively 
advising the research team; the term ‘PPI advisor’ is used within this article, following consultation with our PPI advi-
sors. They were involved during idea generation and discussions about whether the study was important to pursue. 
In addition, they advised the research team during the study setup helping to write the plain English summary, the 
participant information sheets and advised on other research activities. Following relevant training, PPI advisors were 
involved in delivering the research including note-taking during focus groups. One PPI advisor also helped analyse 
the focus group transcripts and attended the UK Stroke Forum to present the results of the study. Reflecting upon 
the impact of the PPI advisors’ contributions to the MoTaStim-Foot study has evidenced that not only was there great 
benefit to the research team and process, but our PPI advisors gained satisfaction from being involved in the research, 
planning, design and delivery. It made them all feel valued and respected and helped one of them find a renewed 
purpose in life. It is important to understand there can be mutual benefit from PPI advisors’ contributions to research.
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to the foot after stroke, in combination with task-specific 
walking training, to improve balance and walking. The 
study setting was an in-patient stroke rehabilitation ward 
and a community-based Stroke Early Supported Dis-
charge service.
The MoTaStim-Foot study has been reported in detail 
elsewhere [1, 20]. The purpose of this follow-up paper 
is to describe the important role of PPI throughout the 
study and discuss the mutual benefits to the trial team 
and the PPI advisors. The different stages of PPI advisor 
contributions are detailed in the GRIPP 2 checklist [21] 
(Additional file 1) and will be discussed, highlighting the 
benefits and challenges from the perspective of both the 
PPI advisors and the research team. The advice offered in 
the RDS handbook for researchers (written by the NIHR, 
p14) [22] (Fig. 1) was also considered when implement-
ing PPI within this study. Consideration was also given 
to how our PPI met the UK standards for public involve-
ment: inclusive opportunities, working together, support 
and learning, governance, communications and impact 
[23]. We reflected on the questions posed for each sec-
tion of the standards, and where we were able to answer 
"yes" to all but one question (e.g., four out of five (80%), 
or three out of four questions (75%)), we considered that 
we had met the standard. Details of how these aspects 
were addressed within the study and suggestions for 
how PPI can be improved in our work in the future were 
tabulated.
PPI advisors were involved in the planning and devel-
opment of the MoTaStim-Foot study through four key 
stages: Stage 1 A series of interactive workshops; Stage 2 
Application for funding; Stage 3 Pilot study; Stage 4 Dis-
semination of findings.
Stage 1 A series of interactive workshops
Workshop A (16/9/13)
PPI began several years before the MoTaStim-
Foot study was commenced; the researchers’ initial 
thoughts and ideas were presented and discussed in a 
90-min workshop with six stroke survivors (3–12 years 
post-stroke) and six carers at Market Drayton Stroke 
Club. The lead researcher (AMA) provided a presen-
tation and demonstration of techniques considered 
appropriate to take forward as a research intervention. 
At the stroke club workshop, members were encour-
aged to give feedback on the proposed intervention 
and make suggestions about its suitability and appro-
priateness. This stage was important for “identifying 
and prioritizing” ([22], p. 14) the proposed research 
(Fig.  1). The group members were consulted about 
whether they thought the proposed research topic was 
appropriate or not and asked to give an indication as 
to whether they thought it should be a priority area 
for research or not. In view of the importance of the 
research for potentially helping people to walk again 
post-stroke all the attendees at the meeting felt it was 
an appropriate area for research and should be seen as 
a priority to be investigated. PPI advisors subsequently 
collaborated with us to refine the topic for research 
and consensus was reached during the discussions. 
Unfortunately, there was no additional funding avail-
able to offer remuneration to the stroke survivors and 
carers involved in this workshop for their time and 
insight, but they considered this to be an interesting 
item of their monthly meeting agenda and were happy 
to have given their time.
Workshop B (24/4/14)
A successful application for funding via an NIHR 
Research Design Service (RDS) PPI bursary supported 
further PPI advisor contributions to the development 
of a research project proposal and enabled appropri-
ate  remuneration  for the PPI advisors’ time and valu-
able contributions. Although financial recompense 
was possible, all the PPI advisors chose to have a gift 
voucher instead as a way of saying "thank you"; travelling 
expenses were offered to all participants involved. This 
second workshop was arranged to inform the “design” 
of the proposed research (22, p. 14) (Fig.  1); this was 
attended by six PPI advisors, three experienced clini-
cians, and two academic members of the team (Fig. 2). 
The bursary funding was used to cover the PPI advisors’ 
travel costs to and from the community-based venue 
(church hall) and provided a buffet lunch and refresh-
ments for the PPI advisors. Additional funding was 
found to enable lunch to be provided for the clinicians 
to say "thank you" for their time and wisdom and also for 
the research team to encourage team building with the 
PPI advisors and clinicians. PPI advisors included three 
stroke survivors (ME, MJ, NP) and three carers (AE, DT, 
AC). The project plans were presented by AMA and dis-
cussed by the whole group in greater detail. Clinicians 
and PPI advisors then attended separate, concurrent 
focus group discussions each lasting for one hour. Dur-
ing the focus groups, the participants were asked to con-
sider the proposed outcome measures and interventions, 
with attention to potential burden and standardisation 
of outcome measures, frequency of treatments delivered, 
and type of intervention to be included in the feasibility 
study. The PPI advisors’ group was facilitated by AMA 
and the clinicians’ workshop was facilitated by SMH. 
PPI advisors and clinicians were then brought together 
to discuss key issues in more detail, ensuring the opin-
ions of stroke survivors were thoroughly understood 
and considered when initialising the design of the study. 
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An independent researcher experienced in PPI engage-
ment (local NIHR RDS PPI advisor) was also invited to 
attend the discussion group with the PPI advisors and 
the joint collaborative discussion; he made notes on all 
the discussions to assist with ensuring that PPI advisors’ 
views were documented accurately and taken forward to 
inform the proposed study.
Fig. 1 How to incorporate patient and public involvement in the research process ( reproduced with permission from the NIHR)
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Stage 2 Application for funding
Two PPI advisors (MJ and AE) expressed an explicit inter-
est and were invited to contribute to the “development 
of the grant proposal” (22, p. 14) (Fig.  1) for an NIHR 
funding application for the MoTaStim-Foot study. They 
specifically reviewed the plain English summary, the pro-
tocol and participant information sheets for the study; 
the advisors made a few minor suggestions to develop 
appropriate wording to ensure that the documents were 
clear and the language was not jargonistic, and to offer 
their opinions on the appropriateness of the protocol 
for stroke survivors. All changes to wording were agreed 
between the lead researcher (AMA) and the PPI advisors 
through discussion; there were no disagreements.
Stage 3 MoTaStim‑Foot pilot study
Following success of the NIHR funding application, the 
MoTaStim-Foot study was set up between March 2015 
and March 2016, and the first participant was recruited 
in May 2016; recruitment continued until November 
2017. Three PPI advisors (AE, JJ and PB) were keen to 
have further involvement with the study. Their prefer-
ences for involvement were discussed and agreed with 
the lead researcher (AMA), and they subsequently were 
welcomed as key members of the research team, attend-
ing the trial management group (AE, PB), assisting 
with data collection (JJ, PB), and analysing data (PB). 
Appropriate means of communication were adopted for 
each PPI advisor according to their individual prefer-
ence. For two of them (AE and PB) this involved email; 
however, one other (JJ) was not a computer user and, 
therefore, other more effective communication meth-
ods were adopted, including telephone calls and postal 
services, to ensure inclusivity as appropriate. 
PB used to teach art prior to his stroke. Despite los-
ing the ability to draw with his dominant hand, he suc-
cessfully developed several images to assist with the 
research documentation. For example, an image depict-
ing how sensory feedback influences motor control 
(Fig.  3), a picture showing the points on the soles of 
the foot that were tested with the Semmes Weinstein 
Fig. 2 Photograph of the people attending the PPI workshop on the 
24/4/14
Fig. 3 Sensory feedback influencing motor control
Fig. 4 Points tested with Semmes Weinstein monofilaments
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Monofilaments (Fig.  4) and a picture representing the 
task-specific walking training intervention (Fig. 5).
AE and PB were appointed as members of the Trial 
Management Group (TMG), attending regular meet-
ings to oversee the study, fulfilling aspirations to have 
PPI advisors involved with “undertaking/manag-
ing” and “monitoring & evaluation” (22, p. 14) of the 
research (Fig.  1). PPI was a standing agenda item for 
the TMG. To assist with PB’s ability to undertake the 
role, he attended a face-to-face Good Clinical Practice 
(GCP) training session, whereas it was not appropriate 
for AE to attend GCP training due to caring commit-
ments for his wife (ME), and he was, therefore, sup-
ported informally on an individual basis by the lead 
researcher (AMA).
Two PPI advisors (JJ and PB) were also trained to 
undertake the role of note-taker for focus groups with 
participants (stroke survivors) in the MoTaStim-Foot 
study. They attended between one (JJ) and three (PB) 
focus group discussions as a member of the research 
team, collecting supplementary data in the form of 
hand-written notes based on observation of behav-
iours, and summarizing key issues that arose. Debrief-
ing sessions were held after each focus group, involving 
the PPI advisors, senior members of the research team 
involved in the focus groups, and the group facilita-
tor (AMA). This enabled further discussion relating to 
the main topic areas and preliminary themes [24], and 
identification of missing topic areas [25] that should 
be considered for exploration in future focus groups. 
Another purpose of the debriefing meetings was to 
offer psychological support to the PPI advisors in case 
of unpredictable emotional response [26] that could 
have potentially been triggered by comments made 
within the focus group that may have elicited memories 
of their own stroke experience and journey.
PB also contributed in his capacity of PPI advisor as a 
member of the research team analysing the focus group 
data once it had been transcribed. The transcriptions 
and initial analyses were shared with PB, which he read 
and subsequently offered additional insights to the analy-
sis through discussions with the wider research team, 
contributing to development and agreement of the final 
themes. As a novice qualitative researcher, it was deemed 
to be more appropriate to invite PB to be part of the anal-
ysis at the second stage. Initial analysis was undertaken 
by three experienced qualitative researchers. This impor-
tant PPI advisor contribution fitted the remit of “ana-
lysing & interpreting” as recommended in the RDS PPI 
handbook for researchers (22, p. 14) (Fig. 1).
Stage 4 Dissemination of findings 
from the MoTaStim‑Foot study
The findings from the MoTaStim-Foot study were pre-
sented during an interactive poster tour by AMA at the 
United Kingdom Stroke Forum in December 2018. PB 
was a co-presenter with AMA, and he played an active 
role in explaining the study and the findings to interested 
conference delegates.
Results
The impact both for the study and the PPI advisors is 
presented for each stage of the MoTaStim-Foot study. 
Table  1 summarises how the different aspects of the 
UK standards for PPI (inclusive opportunities, working 
together, support and learning, governance, communica-
tions and impact) [23] were met and could be improved 
in relation to the MoTaStim-Foot study. Success in meet-
ing the standards  was achieved, based on being able to 
answer "yes" to the proposed success criteria (questions), 
(able to answer at least four out of five (80%), or three out 
of four (75%) questions posed in each section).
Stage 1
Workshop A
During workshop A, stroke club members agreed that 
being able to feel their feet accurately was important 
for function e.g., balance, standing and walking. Ver-
bal consensus was gained through informal discussions, 
ensuring everyone’s opinion was heard, and the group 
advocated that the research should be taken forward. 
One stroke survivor (MJ) felt a lack of sensory feedback 
to the foot increased the chance of tripping stating:
"On my part I still remember the difficulties I expe-
rienced with my affected foot and to a degree still 
experience them today, nine years post stroke. Loss of 
Fig. 5 Task specific walking training
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sensitivity and on occasion hyper-sensitivity made/
makes walking a problem. I am absolutely certain it 
is an appropriate area for future research".
As a result of the consensus from the group, the 
research team were reassured that the proposed project 
was relevant to stroke survivors and felt it would have 
credibility with service users and carers. The involvement 
of PPI advisors at this stage was valuable to the research 
team; however, it was also of clear benefit to the stroke 
club members, who felt that their opinion and experi-
ence was respected (evidenced by post-event feedback 
by email from the group chairperson) and their input to 
the project ideas at this stage would be used to develop a 
better and more credible research project. MJ became an 
active member of the research team from this point on.
Workshop B
At workshop B, new and useful suggestions were made 
for consideration during the protocol development 
stage. In particular, these included: fatigue manage-
ment; types of shoe to be worn; and potential burden of 
the outcome measures, which contributed to finalising 
the choice of measures for the study.
The research team had proposed that stroke partici-
pants in the MoTaStim-Foot study should maintain a 
daily diary of their experiences of the study and any 
subjective changes noted in their foot or balance/walk-
ing; feedback from one PPI advisor suggested that the 
diary should include clear prompts to make it easier for 
stroke survivors to complete.
"To help people fill it in, keep it simple".
This important advice was taken on board when 
developing the study, and the daily diaries were con-
structed with clear verbal and visual prompts to facili-
tate completion. The understanding from PPI advisors 
that completing a daily diary without prompts was 
something that the research team had not considered 
specifically, and this insight from PPI advisors was of 
great benefit to the study participants (stroke survivors) 
who were subsequently asked to record their subjective 
experiences on a daily basis throughout the study.
Stage 2 Application for funding
PPI advisor contributions from MJ and AE were essen-
tial to inform the funding application for the study. 
Guidance relating to wording of the plain English sum-
mary was particularly useful, ensuring appropriate 
terminology was used. MJ was extremely passionate 
about this research and instrumental, with assistance 
from AE, in helping to develop the MoTaStim-Foot 
protocol and essential documentation, such as the par-
ticipant information sheets for the study, once funding 
had been secured. Such was the success of this aspect 
that comments from the Research Ethics Commit-
tee complimented the role of PPI advisors within the 
MoTaStim-Foot study. Sadly, MJ passed away before the 
study was completed; however, his wife (JJ) continued 
as an integral part member of the research team, along 
with AE and PB, who is co-author on this paper. The 
valuable suggestions from the PPI advisors strength-
ened the application helping to secure funding. Equally, 
fulfilling the role of PPI advisor for the application 
stage was beneficial for the advisors, with the value and 
meaning of this role clearly expressed in the vignettes. 
MJ reported to his wife that he felt “a sense of pride and 
satisfaction” and that he had “a purpose” and felt it was 
“rewarding… to be part of such a great team”.
Stage 3 MoTaStim‑Foot pilot study
PPI in the MoTaStim-Foot study was an important com-
ponent and was fully integrated into the study manage-
ment and overall research process. There were many 
ways in which the PPI advisors’ contributions added 
value to the research process. PB was an art tutor prior 
to his stroke and, despite the fact he had lost the use of 
his dominant right hand, he produced some exceptional 
images, using his left hand, that were helpful when pre-
senting and explaining information about the study, 
including the importance of sensory information to drive 
motor control (Figs. 3, 4, 5).
He also drew images to help with presenting infor-
mation relating to the study interventions, which were 
included in written reports of the study [20].
Specific training was provided for PPI advisors, includ-
ing a half-day session to train two PPI advisors (JJ, PB) to 
be able to undertake the role of note-taker, and further 
informal training to enable PB to undertake the addi-
tional role contributing to the analysis of the focus groups 
and development of the final themes. Both PPI advisors 
appreciated the training they received to help them fulfil 
their roles within the research team. PPI advisor contri-
butions were costed and funded within the NIHR appli-
cation and this enabled appropriate remuneration to the 
PPI advisors, based upon INVOLVE guidelines [4], for 
both travel costs and their time. Although money was 
offered, all PPI advisors preferred the option of taking a 
gift voucher instead as a "thank you" for their time. The 
training included NIHR Good Clinical Practice (GCP) 
training, which was completed by one PPI advisor (PB), 
covering the “international ethical, scientific and practi-
cal standard to which all clinical research is conducted” 
[27]. When completing the GCP training, PB had the 
confidence to remind the facilitator to refrain from using 
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technical jargon and abbreviations, to increase his abil-
ity to understand the information delivered within the 
course.
The notetaker role was successfully carried out by two 
PPI advisors (PB and JJ) for the four focus groups under-
taken in the study. JJ initially felt “out of her depth” and 
"threatened" by being involved because she was  not sure 
that she had the skills: she had never had any academia 
within her life, and this role was new to her. JJ reported 
that she liked to learn from other PPI advisors (PB) and 
felt supported by the research team. The added insight 
from the PPI advisors was extremely valuable. PB and 
JJ were able to empathise with the participants (stroke 
survivors) and ‘looked out’ for those who were perhaps 
reluctant to communicate their ideas, helping to facili-
tate their input. As a carer and a stroke survivor, both 
PPI advisors complemented each other well, with both 
bringing experience from a different point of view and 
two ‘separate sets of eyes’. As a carer, JJ was looking more 
at the stroke survivors’ and carers’ needs, whereas PB (a 
stroke survivor) was looking more at the effects of stroke 
on the stroke survivors. Furthermore, their input to the 
summary section of the focus group discussions was 
invaluable; they could put themselves into the shoes of 
the stroke survivors, adding a different perspective, and 
ensuring any aspects which may have been overlooked by 
the researcher (AMA) were included. Including PPI advi-
sor representation in the post-focus group debrief meet-
ings also proved useful, enabling initial analysis of the 
focus groups to be commenced, with PPI advisor input.
However, it is clear from PB’s vignette that being able 
to successfully achieve the note-taker role in the focus 
groups was an important aspect in his own recovery post 
stroke. The sense of achievement he felt boosted his own 
confidence and he stated that “it made me feel really good 
contributing to something so important”, and it was "good 
to be part of a team again". This helped him realise that, 
whilst the stroke had affected him physically, it had “not 
hampered his ability to get involved in research and to 
help other stroke survivors”. PB found the whole experi-
ence to be "uplifting", with "no negatives whatsoever". 
This sentiment was repeated by JJ as well. Their peer 
relationship was mutually beneficial despite their differ-
ent experiences of stroke and their backgrounds. PB ben-
efitted from meeting someone who had previously been 
involved as a PPI advisor and found it useful to speak to 
someone who had life experience of living with someone 
who had had a stroke. JJ was, therefore, experienced from 
a different point of view. JJ also reported that she found 
it helpful to work together and stated that she "liked to 
learn from" PB too.
Stage 4 Dissemination of the findings 
of the MoTaStim‑Foot study
Having a stroke survivor (PB) involved when presenting 
the results of the study at the UK Stroke Forum added 
another dimension, a stroke survivor’s perspective, to 
dissemination (Fig.  6), and met the RDS recommenda-
tions for PPI [22] (Fig. 1). The conference delegates were 
keen to question him and find out more about his role 
within the study team.
The results of the MoTaStim-Foot study were also 
reported back to the study participants; they were all 
invited to a presentation at the University, with lunch 
and refreshments provided. A total of six participants 
and three carers attended (Fig.  7). In their position of 
Fig. 6 Presenting at the UK Stroke Forum
Fig. 7 Participants present for the feedback session about 
MoTaStim-Foot
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PPI advisors for the study JJ and PB attended this feed-
back session. Although there was no formal role for 
them at this presentation, they were integral members 
of the research team, and it was considered that their 
presence at the meeting would be useful in case any 
participants had questions they wanted to address to 
them specifically as PPI advisors; it also gave an oppor-
tunity for those attending to find out more, through 
informal discussions over lunch, about the role of being 
a PPI advisor within our research team. Several par-
ticipants from the MoTaStim-Foot study expressed an 
interest in undertaking this role, as well as participating 
in further research studies in the future. It was impor-
tant for the PPI advisors to be invited and be part of 
this meeting, recognising the accomplishment of the 
MoTaStim-Foot study and the role they played in mak-
ing the study successful. It also gave us another oppor-
tunity to thank them for the role they played in the 
study, helping to ensure they felt valued and respected.
The ability to be an important ‘cog in a wheel’ again, 
and feeling appreciated, comes across clearly in the PPI 
advisors’ vignettes below:
Vignette 1 (PB):
"Back in January 2017 I was asked by Alison if I would 
like to be a patient and public input (PPI) volunteer on a 
study that Keele University were doing called MoTaStim-
Foot. I had been recommended by the physios from the 
[Haywood] hospital because of my attitude and determi-
nation to recover and to help in any research that might 
help myself or others. My background and job (a prison 
officer/tutor) meant communication was a strong point, 
I also taught art and although right-handed/right side 
affected, I managed to retrain my brain to produce paint-
ings and drawings with my left hand. Some of these were 
produced to use in the research documentation. I was 
eager to help in any way I could and took any task given.
I was given the chance to increase my knowledge by 
doing  GCP training at a hospital along with a group 
of hospital staff; it was at this stage that I felt out of my 
depth when I began to read the PowerPoint slides, but I 
didn’t suffer in silence and asked if they could stop using 
abbreviations that only mean something to people who 
work as medical professionals. They apologised and the 
whole day was very useful, learning things like how partic-
ipants were recruited and how information was recorded 
and handled safely and securely.
My first task was a trial management group. I’m a peo-
ple person that loves to meet and interact with others, so 
this study was a good thing to be involved with, as I feel 
it helped me put some things into perspective and share 
my experience with others to further their understand-
ing of stroke and the effects on one’s life. Being a note 
taker was an interesting role, spotting people that weren’t 
engaging was a vital part whether that was because they 
were unable to do so because someone was too eager to 
share, or they were not comfortable due lack of confidence 
or communication difficulties due to their stroke. I found 
this very useful and became very good at it towards the 
end; it made me feel really good contributing to something 
so important. I found that doing the PPI role increased 
my need to help, so I became a volunteer with the Stroke 
Association and later became a stroke ambassador. I 
also got involved in a community-based music making 
group (STROKESTRA®-Stoke) which gave me a chance 
to take part and improve certain things that I set as tar-
gets, things that I felt were affecting my life due to stroke, 
and meet some extraordinary people who were living with 
similar things, learning how they cope and how their life 
has changed. I personally feel that my life has improved, 
and I have met some great people and learnt things about 
myself that have made my life easier and improved the life 
of others".
Vignette 2 (MJ and JJ’s story, told by JJ)
MJ: “Mel became a stroke survivor at the age of 55 years. 
He was told ‘"you may never walk again, you may never 
drive again and you may never work again"’. He did walk 
and drive again; however, he was unable to work again as 
an ophthalmic optician. Mel was passionate about get-
ting stroke survivors back into useful lives. Being a stroke 
survivor himself, Mel knew the importance of research 
and trials and was so delighted to be asked to be a PPI 
volunteer for Alison. He always had a spring in his step 
when he went to Keele, enjoyed the company of the staff 
and patients, and felt a sense of pride and satisfaction, 
also a purpose using his knowledge. Mel knew the research 
trial would benefit his fellow stroke survivors, and had he 
lived, he would have seen their success. He would return 
home and tell me how rewarding it was to be part of such 
a great team, and he knew every effort was being made 
to make trials happen, I know he enjoyed ‘taking part’ at 
Keele. Sadly, Mel died in May 2016, never to know the 
outcome of Alison’s trial; however, he would have been so 
proud of Alison’s achievement”.
JJ: “This is now where I came into Alison’s life, she asked 
me if I would like to be a PPI volunteer. I have no qualifi-
cations, only life skills, so felt very honoured to be asked, 
but I did feel ‘out of my depth’ as I’m not an academic, 
learning isn’t easy. The training given was useful and with 
each PPI session I became more comfortable and grew in 
confidence. I saw patients not able to stand or walk, given 
insoles to stimulate the foot and physiotherapists working 
on the foot, blossom into being able to walk and do things 
we take for granted not only physically but mentally. 
Observing what clinical trials do from my perspective 
was an eye-opener, and I only hope the department can 
continue in more research and clinical trials. I know from 
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my personal experience there is ‘LIFE AFTER STROKE’, I 
would continue to be a PPI volunteer if asked”.
The details regarding how the PPI advisors’ contribu-
tions to the MoTaStim-Foot study met the UK stand-
ards for patient involvement, and which aspects can be 
improved for the future are summarised in Table 1.
In summary, there were numerous positive outcomes 
resulting from the PPI advisors’ contributions to the 
MoTaStim-Foot study. PPI advisors helped to shape the 
research design and documentation, input into how the 
research was undertaken via their role in the trial man-
agement group, assist in data collection and dissemina-
tion of the results. There were no specific negative effects 
to having such an intensive level of PPI for the study; 
however, additional strategic planning and finance were 
necessary to ensure appropriate lines of communication 
were used and that PPI advisors were appropriately com-
pensated for their time supporting the study.
Discussion
The PPI advisors played an important role within the 
research team for the MoTaStim-Foot study. Their 
input was valuable right from the initial inception of the 
research ideas through to the dissemination of the work. 
Indeed, seven of the eight suggested ideas for incorpo-
rating PPI in the research process included in the RDS 
handbook for researchers (written by the NIHR, p. 14) 
[22] were fulfilled within this study process (Fig. 1). The 
idea not included was implementation, which would not 
have been appropriate; this was early-stage research, 
designed as a feasibility study.
It was particularly insightful to have a stroke survivor 
and carer as research team members when summarizing 
the focus group discussions and seeking verification from 
the participants. It brought a deeper level of understand-
ing, by virtue of their ability to understand and empathise 
appropriately about how it feels to be a stroke survivor.
Respect for the PPI advisors’ opinions relating to the 
progression of the study was evident from everyone in 
the study team; for example during the trial management 
group meetings, where the opinions of PPI advisors were 
listened to and considered, and where suggested changes 
were agreed by the whole team following discussion, 
these were actioned [5, 9].
Researchers and PPI advisors all agreed that there were 
no specific challenges to report associated with the PPI 
advisors’ contributions to the MoTaStim-Foot study; 
however, it is acknowledged that there were occasions 
when PPI advisors’ advice could not be followed. This 
could be perceived by PPI advisors that their opinion 
was not valued. An example of this was that in work-
shop B when it was suggested that footwear was stand-
ardized when undertaking the outcome measures. It 
was not feasible or appropriate to provide standardized 
footwear for all the participants in the study; however, 
this suggestion was considered. As a compromise it was 
ensured that each participant wore the same footwear on 
all occasions when undertaking the baseline and outcome 
assessments.
It is important that PPI advisors are offered appropri-
ate  remuneration for their time and travel expenses [5]. 
It was possible to ensure payments were offered to all our 
PPI advisors, because PPI advisors’ contributions were 
appropriately costed and funded for this study, based on 
the INVOLVE recommendations [9].
We acknowledge a limitation relating to the diversity 
within our PPI group of advisors. This may have meant 
that the opinions and needs of stroke survivors from 
other cultures and age groups were not adequately repre-
sented within our study.
Our approach to PPI in research fits well with the 
UK standards for public involvement [23], facilitating 
working together and implementation of appropriate 
support and learning, good communication, enabling 
PPI advisors to influence governance of the research 
and evaluating the impact of PPI. After working closely 
with the PPI advisors and conversing informally on reg-
ular occasions, it was evident that it was not only the 
research team and processes that benefitted from their 
input; PPI advisors also gained a great deal from feeling 
like they were contributing to the research process. PB 
benefitted from being a valued and active member of a 
team again, which not only gave him a reason to leave 
the house but restored his faith in his ability to be a use-
ful member of society and, through his contributions, 
to benefit other stroke survivors. His experience was 
described as being "uplifting" and he was adamant that 
he was unable to identify any negative aspects associ-
ated with his input. The confidence that PB gained by 
being a PPI advisor even facilitated his next step on his 
road to recovery post-stroke, prompting him to volun-
teer for the Stroke Association and later to become a 
Stroke Ambassador. For JJ, who was initially daunted by 
being invited to contribute to research as a PPI advisor, 
her experiences were again beneficial; she has reflected 
on her ability to better understand research and stated 
that she wished she had been involved in that capacity 
earlier on in her role as carer.
Another aspect to consider is the researchers’ perspective 
and what was learnt or gained from working with PPI advi-
sors. Some researchers have disclosed a better understand-
ing of the experiences of the people living with the condition 
being researched [28]; however, as both the key researchers 
are physiotherapists with many years of experience working 
with stroke survivors it was perhaps not an expectation that 
"experiential knowledge" ([29] p. 7) would increase. One 
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aspect that we were perhaps made more aware of was the 
importance of using plain language and avoiding acronyms 
when working with PPI advisors. It has been advised that 
the use of abbreviations is kept to a minimum and an expla-
nation given when they are first used, short sentences are 
used, and technical terms avoided when developing docu-
mentation for health [30]. Our recommendation is that this 
approach is used when working with PPI advisors too.
Our whole research team and the wider governance 
group within Keele University believe it is important to 
build relationships over time and to encompass PPI advi-
sors as significant, respected, and valued members of the 
research team; these factors have been acknowledged 
previously as being important when working with PPI 
advisor members [10].
In summary, from our experience of the MoTaStim-
Foot study and learning about the mutual benefits of 
PPI, the following are key aspects of PPI in research that 
we will endeavour to continue to include in our own 
research:
• Early involvement of PPI advisors in discussions 
about the planned research
• PPI advisors’ advice when writing the plain English 
summary
• Appropriately funded remuneration  for PPI advisors’ 
time and other expenses
• Full integration of at least one PPI advisor into the 
research team e.g., Trial Management Group mem-
ber
• Involvement of at least one PPI advisor in interpret-
ing research findings
• Provision of appropriate (and funded) training for 
PPI advisors to fulfil their roles
• Co-presentation and dissemination of research find-
ings at high profile national or international confer-
ences, with full funding provided to cover costs
Conclusion
Reflecting upon the PPI within the MoTaStim-Foot study 
has given an opportunity to fully appreciate the impor-
tance and value of PPI advisors’ contributions to both the 
research team and the PPI advisors, further fulfilling the 
“monitoring & evaluation” aspect of incorporating PPI 
in the research process (22) p. 14). This report has high-
lighted that it is possible to work in partnership with PPI 
advisors, with them influencing the research process at 
all stages from initial ideas to delivery and dissemination 
of research findings.
This exemplary PPI advisor input has not only 
improved the credibility of the research; it has also 
enhanced the PPI advisors’ perception of their own 
value and importance within the research process, giving 
added purpose to their life after stroke. PB appreciated 
being respected and valued within the research team and, 
as a gift to demonstrate his appreciation of his experi-
ence working as a PPI advisor for MoTaStim Foot study, 
he gave AMA an image he had drawn depicting his own 
brain and the effect of his stroke. The image portrays the 
reforming of neurological pathways (Fig. 8); this is exactly 
what the sensory stimulation delivered within the MoT-
aStim-Foot study aimed to achieve. The mutual benefit 
of PPI advisor input within our research is a shared mis-
sion that we plan to continue in the future, and an aim we 
hope others will also adopt.
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